Caremark was found liable in June, and Philadelphia federal court Chief Judge Mitchell Goldberg ordered the company to pay ...

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...

A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

Whistleblower Sarah Behnke's lawsuit leads to $290 million judgment against CVS Caremark for overcharging Medicare on prescription drugs in 2013 and 2014.

Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...

An unsealed 2014 lawsuit by an Aetna actuary whistleblower against CVS Caremark, the insurer's pharmacy benefit manager, accuses the PBM of billing the government for prescription drugs at a greater ...

CVS Caremark will serve approximately 9.7 million Aetna PBM members and administer approximately $9.5 billion in annual drug spend as it applies its unique, integrated pharmacy care delivery model ...

CVS Caremark will serve approximately 9.7 million Aetna PBM members and administer approximately $9.5 billion in annual drug spend as it applies its unique, integrated pharmacy care delivery model ...

CVS Caremark has expertise and access to customers’ pharmaceutical information and medical needs, so it makes sense that the company would want to expand that to include not just pharmacy, but ...

CVS and Caremark Rx closed a $21 billion merger of equals in 2007. CVS more recently has moved deeper into health care, offering vaccinations by pharmacists and helping customers deal with asthma ...

CVS Caremark will run Aetna's pharmacy-benefit business for at least the next 12 years, according to the terms of a deal announced last night. But analysts on this morning's conference call on ...